0001840315-23-000004.txt : 20230526
0001840315-23-000004.hdr.sgml : 20230526
20230526095745
ACCESSION NUMBER: 0001840315-23-000004
CONFORMED SUBMISSION TYPE: 144/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230526
DATE AS OF CHANGE: 20230526
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 23963672
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocumension Therapeutics
CENTRAL INDEX KEY: 0001840315
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144/A
BUSINESS ADDRESS:
STREET 1: 56F, ONE MUSEUM PLACE
STREET 2: 669 XIN ZHA ROAD
CITY: JING'AN DISTRICT, SHANGHAI
STATE: F4
ZIP: 200041
BUSINESS PHONE: 862122893688
MAIL ADDRESS:
STREET 1: 56F, ONE MUSEUM PLACE
STREET 2: 669 XIN ZHA ROAD
CITY: JING'AN DISTRICT, SHANGHAI
STATE: F4
ZIP: 200041
FORMER COMPANY:
FORMER CONFORMED NAME: OcuMension Therapeutics
DATE OF NAME CHANGE: 20210113
144/A
1
primary_doc.xml
144/A
0001968940-23-000001
0001840315
XXXXXXXX
LIVE
0001314102
EyePoint Pharmaceuticals, Inc.
000-51122
480 PLEASANT STREET
SUITE B300
WATERTOWN
MA
02472
617-926-5000
Ocumension Therapeutics
Director
Common Stock
Tiger Brokers (Singapore) Pte. Ltd. Singapore
1 Raffles Place, #35-61
One Raffles, Place Tower 2,
Singapore
U0
048616
1
5.93
37312647
05/26/2023
Nasdaq
Common Stock
12/31/2020
Through a private placement from the issuer of the securities
Eyepoint Pharmaceuticals, Inc.
N
3010722
12/31/2020
Good funds
Y
This Form 144/A is being filed to amend the Form 144 filed on May 26, 2023 to change (i) the Number of Shares or Other Units to Be Sold from 3010722 to 1, (ii) the Aggregate Market Value from 17853581.46 to 5.93 and (iii) the Number of Shares or Other Units Outstanding from 34301926 to 37312647.
05/26/2023
YE LIU